drugset
drugset / Trial / NCT03414294

A Study to Evaluate the Safety of K-755 in Healthy Volunteers

NCT03414294 ↗

Phase 1 Completed 121 enrolled Kowa Company, Ltd.
RandomizedSequentialDouble-blindOther

Summary

This is a Phase 1 study designed to explore the safety, tolerability and pharmacokinetics of K-755 following oral administration to healthy male and female volunteers.

Timeline

Start
2018-02-27
Primary completion
2019-11-14
Completion
2019-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject K-755 Unknown — Oral

Indications

No indication recorded.